A Randomized, Double-Blind, Placebo-Controlled Trial of Naltrexone in the Treatment of Concurrent Alcohol Use Disorder and Pathological Gambling

REFERENCES

• Grant J E, Kim S W, Potenza M N. Advances in the pharmacological treatment of pathological gambling. J Gambl Stud 2003; 19: 85–109
   PubMedGoogle Scholar
• Blanco C, Petkova E, Ibanez A, Saiz-Ruiz J. A pilot placebo-controlled study of fluvoxamine for pathological gambling. Annals Clin Psychiatry 2002; 14: 9–15
   PubMedGoogle Scholar
• Kim S W, Grant J E, Adson D E, et al. A double-blind placebo-controlled study of the efficacy and safety of paroxetine in the treatment of pathological gambling. J Clin Psychiatry 2002; 63: 501–507
   PubMed Web of Science ®Google Scholar
• Grant J E, Kim S W, Potenza M N, et al. Paroxetine treatment of pathological gambling: a multi-centre randomized controlled trial. Int Clin Psychopharm 2003; 18: 243–249
   PubMed Web of Science ®Google Scholar
• Kim S W, Grant J E. An open naltrexone treatment study in pathological gambling disorder. Int Clin Psychopharm 2001; 16: 285–289
   PubMed Web of Science ®Google Scholar
• Kim S W, Grant J E, Adson D E, Shin Y C. Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling. Biol Psychiatry 2001; 49: 914–921
   PubMed Web of Science ®Google Scholar
• Grant J E, Potenza M N, Hollander E, et al. Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling. Amer J Psychiatry 2006; 163: 303–312
   PubMed Web of Science ®Google Scholar
• Guardia J, Caso C, Arias F, et al. A double-blind, placebo-controlled, study of naltrexone in the treatment of alcohol-dependence disorder: results from a multicenter clinical trial. Alc: Clin Exp Res 2002; 26: 1381–1387
   PubMed Web of Science ®Google Scholar
• Balldin J, Berglund M, Borg S, et al. A 6-month controlled naltrexone study: Combined effect with cognitive behavioral therapy in outpatient treatment of alcohol dependence. Alc: Clin Exp Res 2003; 27: 1142–1149
   PubMed Web of Science ®Google Scholar
• Anton R F, O'Malley S S, Ciraulo C A, et al. Combined pharmacotherapies and behavioral interventions for alcohol dependence. JAMA 2006; 295: 2003–2017
   PubMed Web of Science ®Google Scholar
• Pettinatti H M, O'Brien C P, Rabinowitz A R, et al. The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking. J Clin Psychopharm 2006; 26: 610–625
   Google Scholar
• Froehlich J, O'Malley S, Hyytia P, et al. Preclinical and clinical studies on naltrexone: what have they taught each other. Alc: Clin Exp Res 2003; 27: 533–539
   PubMedGoogle Scholar
• Krystal J H, Gueorguieva R, Cramer J, Collins J, Rosenheck R. Naltrexone is associated with reduced drinking by alcohol dependent patients receiving antidepressants for mood and anxiety symptoms: results from VA Cooperative Study No. 425, “Naltrexone in the treatment of alcoholism.”. Alc: Clin Exp Res 2008; 32: 85–91
   Google Scholar
• Petry N M. Pathological Gambling: Etiology, Comorbidity and Treatment. American Psychological Association, Washington, DC 2005
   Google Scholar
• Spunt B, Dupont I, Lesieur H, et al. Pathological gambling and substance misuse: A review of the literature. Subst Use Misuse 1998; 33: 2535–2560
   PubMed Web of Science ®Google Scholar
• Kausch O. Patterns of substance abuse among treatment-seeking pathological gamblers. J Subs Abuse Treat 2003; 25: 263–270
   PubMed Web of Science ®Google Scholar
• Toneatto T, Skinner W, Dragonetti R. Patterns of substance use in treatment-seeking problem gamblers: Impact on treatment outcomes. J Clin Psychology 2002; 58: 853–859
   PubMed Web of Science ®Google Scholar
• Crockford D N, el-Guebaly N. Naltrexone in the treatment of pathological gambling and alcohol dependence. Can J Psychiatry 1998; 43: 86
   PubMed Web of Science ®Google Scholar
• Berg B J, Pettinati H M, Volpicelli J R. A risk-benefit assessment of naltrexone in the treatment of alcohol dependence. Drug Safety 1996; 4: 274–282
   Google Scholar
• Volpicelli J R, Rhines K C, Rhines J R, et al. Naltrexone and alcohol dependence. Arch Gen Psychiatry 1997; 54: 737–742
   PubMed Web of Science ®Google Scholar
• Morris P LP, Hopwood M, Whelan G, et al. Naltrexone for alcohol dependence: a randomized controlled trial. Addiction 2001; 96: 1565–1573
   PubMed Web of Science ®Google Scholar
• Toneatto T, Ladouceur R. The treatment of pathological gambling: a critical review of the literature. Psychol Addict Beh 2003; 17: 284–292
   PubMed Web of Science ®Google Scholar
• Hodgins D C, Holub A. Treatment of Problem Gambling. Research and Measurement Issues in Gambling Studies, G Smith, D Hodgins, R Williams. Elsevier, San Diego, Calif 2007; 372–399
   Google Scholar
• Spitzer R L, Williams J BW, Gibbons M, First M B. Structured Clinical Interview for DSM-IV. American Psychiatric Press, Washington, DC 1994
   Google Scholar
• Sobell L C, Sobell M B. Timeline follow back: A calendar method for assessing alcohol and drug use. Addiction Research Foundation, Toronto 1996
   Google Scholar
• Skinner H, Allen B A. Alcohol dependence syndrome: measurement and validation. J Abnorm Psychol 1982; 91: 199–209
   PubMed Web of Science ®Google Scholar